APA

Smith R. A., Raugi D. N., Wu V. H., Leong S. S., Parker K. M., Oakes M. K., Sow P. S., Ba S., Seydi M. & Gottlieb G. S. (20160913). The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. : Antimicrobial agents and chemotherapy.

Chicago

Smith Robert A, Raugi Dana N, Wu Vincent H, Leong Sally S, Parker Kate M, Oakes Mariah K, Sow Papa Salif, Ba Selly, Seydi Moussa and Gottlieb Geoffrey S. 20160913. The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. : Antimicrobial agents and chemotherapy.

Harvard

Smith R. A., Raugi D. N., Wu V. H., Leong S. S., Parker K. M., Oakes M. K., Sow P. S., Ba S., Seydi M. and Gottlieb G. S. (20160913). The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. : Antimicrobial agents and chemotherapy.

MLA

Smith Robert A, Raugi Dana N, Wu Vincent H, Leong Sally S, Parker Kate M, Oakes Mariah K, Sow Papa Salif, Ba Selly, Seydi Moussa and Gottlieb Geoffrey S. The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. : Antimicrobial agents and chemotherapy. 20160913.